Brief: Laurus Labs To Acquire 26.62% Stake In Immunoadoptive Cell Therapy For About 460 Mln Rupees
19/11/2021 07:53
Nov 19 (Reuters) - Laurus Labs Ltd LAUL.NS :
* SIGNED INVESTMENT AGREEMENT WITH IMMUNOADOPTIVE CELL
THERAPY
PRIVATE LIMITED
* TO ACQUIRE 26.62% STAKE IN IMMUNOADOPTIVE CELL THERAPY FOR
ABOUT
460 MILLION RUPEES
* CO'S SENIOR MANAGEMENT WOULD ALSO INVEST IN IMMUNOACT FOR
5.64%
STAKE FOR ABOUT 97.5 MILLION RUPEES
Source text for Eikon: ID:nBSEkTNjk
Further company coverage: LAUL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Laurus Labs
See all newsIndia's Laurus Labs hits record high as Q2 profit more than doubles
Brief: Laurus Labs Declares Dividend Of 1 Rupee Per Share
Brief: Laurus Labs Invests 1.08 Billion Rupees Into KRKA Pharma Via Rights Issue
Brief: Laurus Labs Invests 120.96 Million Rupees In Kurnool Renewables Via Rights Issue
Four Indian stocks to be added, three removed from key global index in MSCI's August rejig